Page:United States Statutes at Large Volume 113 Part 2.djvu/872

 113 STAT. 1501A-354 PUBLIC LAW 106-113—APPENDIX F (2) by amending paragraph (2) of subsection (b) to read as follows: "(2) CAPITATED PAYMENT RATE DEFINED. —In this subsection, the term 'capitated payment rate' means, with respect to a demonstration project— "(A) in its first year, a rate established for the project by the Secretary, using the most current available data, in a manner that ensures that aggregate pa3anents under the project will not exceed the aggregate pa3anent that would have been made for ambulance services under part B of title XVIII of the Social Security Act in the local area of government's jurisdiction; and "(B) in a subsequent year, the capitated payment rate established for the previous year increased by an appropriate inflation adjustment factor.". SEC. 226. PHASE-IN OF PPS FOR AMBULATORY SURGICAL CENTERS. If the Secretary of Health and Human Services implements a revised prospective payment system for services of ambulatory surgical facilities under section 1833(i) of the Social Security Act (42 U.S.C. 13951(i)), prior to incorporating data from the 1999 Medicare cost survey or a subsequent cost survey, such system shall be implemented in a manner so that— (1) in the first year of its implementation, only a proportion (specified by the Secretary and not to exceed Va) of the payment for such services shall be made in accordance with such system and the remainder shall be made in accordance with current regulations; and (2) in the following year a proportion (specified by the Secretary and not to exceed %) of the payment for such services shall be made under such system and the remainder shall be made in accordance with current regulations. SEC. 227. EXTENSION OF MEDICARE BENEFITS FOR IMMUNO- SUPPRESSIVE DRUGS. (a) IN GENERAL.—Section 1861(s)(2)(J)(v) (42 U.S.C. 1395x(s)(2)(J)(v)) is amended by inserting before the semicolon at the end the following: "plus such additional number of months (if any) provided under section 1832(b)". (b) SPECIFICATION OF NUMBER OF ADDITIONAL MONTHS. — Section 1832 (42 U.S.C. 1395k) is amended— (1) by redesignating subsection (b) as subsection (c); and (2) by inserting after subsection (a) the following new subsection: " (b) EXTENSION OF COVERAGE OF IMMUNOSUPPRESSIVE DRUGS.— " (1) EXTENSION.— " (A) IN GENERAL. —The Secretary shall specify consistent with this subsection an additional number of months (which may be portions of months) of coverage of immunosuppressive drugs for each cohort (as defined in subparagraph (C)) in a year during the 5-year period beginning with 2000. The number of such months for the cohort— "(i) for 2000 shall be 8 months; and "(ii) for 2001 shall, subject to paragraph (2)(A)(i), be 8 months. " (B) APPLICATION OF ADDITIONAL MONTHS IN A YEAR ONLY TO COHORT IN THAT YEAR. —

�